🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Transfer of Energy Capacitive and Resistive on Chronic Discogenic Sciatica

RecruitingNAAges 35 Years - 50 YearsMaleCairo University
NCT07841405 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate the effect of Transfer of Energy Capacitive and Resistive (TECAR) on pain, functional disability and electrophysiological parameters in adults with chronic discogenic sciatica . The main questions it aims to answer are: • Is there significant effect of TECAR therapy on pain, functional disability and Electrophysiological parameters (H-reflex latency and amplitude) ? Researchers will compare effect of adding TECAR therapy to conventional physical therapy program (TENS, hot pack, stretching exercises and core stability exercises) Vs conventional physical therapy program alone to see if there is a beneficial effect of adding TECAR therapy to physical therapy program Participants in study group will receive TECAR therapy in addition to conventional PT program while participants in control group will receive conventional PT program

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 30-50 years * Unilateral chronic discogenic sciatica at L5-S1, MRI confirmed * Symptom duration more than 3 months * Pain score ≥ 4 on the Visual Analogue Scale (VAS) * Ability to participate in outpatient physiotherapy Exclusion Criteria: * Previous lumbar spine surgery * Pacemaker or metallic implants * Peripheral neuropathy or systemic neurological disorders * Severe sensory loss * Skin lesions at the treatment site * Recent corticosteroid injection (\< 3 weeks)
💊

What it tests

  • Transfer of Energy Capacitive and Resistive (TECAR) therapy
  • conventional physical therapy program
📍

Where

1 site
Faculty of Physical Therapy Cairo University
Giza, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy